ST Pharm Co Ltd (237690)

Currency in KRW
94,800
+500(+0.53%)
Delayed Data·
237690 Scorecard
Full Analysis
Trading at a high earnings multiple
237690 is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
93,50095,100
52 wk Range
66,600120,800
Key Statistics
Bid/Ask
94,700.00 / 94,800.00
Prev. Close
94,300
Open
94,300
Day's Range
93,500-95,100
52 wk Range
66,600-120,800
Volume
69.73K
Average Volume (3m)
148.81K
1-Year Change
-17.29%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
237690 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
120,778
Upside
+27.40%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

ST Pharm Co Ltd Company Profile

ST Pharm Co.,Ltd., provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally. The company offers small molecule and generics, an ingredient for treating viral infections; oligonucleotide based products, such as siRNA/microRNA, antisense, aptamer, decoys, and other novel oligos; monomer; and mRNA for vaccines and therapeutics. It also offers pre-clinical and bioanalytical R and D solutions. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is headquartered in Siheung-si, South Korea.

Employees
655

Compare 237690 to Peers and Sector

Metrics to compare
237690
Peers
Sector
Relationship
P/E Ratio
56.0x14.1x−0.5x
PEG Ratio
1.20−0.230.00
Price/Book
3.8x0.9x2.6x
Price / LTM Sales
6.4x0.6x3.3x
Upside (Analyst Target)
27.3%32.8%38.7%
Fair Value Upside
Unlock34.5%5.0%Unlock

Analyst Ratings

9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 120,778
(+27.40% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1,686.52%
Dividend Yield
0.53%
Industry Median 0.95%
Annualised payout
500.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jul 24, 2025
EPS / Forecast
269.00 / --
Revenue / Forecast
68.20B / 65.77B
EPS Revisions
Last 90 days

237690 Income Statement

People Also Watch

52,100
214150
-2.07%
63,700
034020
+0.63%
161,100
009150
+1.00%
46,050
000990
-1.29%
29,700
028050
+3.13%

FAQ

What Stock Exchange Does ST Pharm Trade On?

ST Pharm is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for ST Pharm?

The stock symbol for ST Pharm is "237690."

What Is the ST Pharm Market Cap?

As of today, ST Pharm market cap is 1.87T.

What Is ST Pharm's Earnings Per Share (TTM)?

The ST Pharm EPS (TTM) is 1,686.52.

When Is the Next ST Pharm Earnings Date?

ST Pharm will release its next earnings report on 29 Oct 2025.

From a Technical Analysis Perspective, Is 237690 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has ST Pharm Stock Split?

ST Pharm has split 0 times.

How Many Employees Does ST Pharm Have?

ST Pharm has 655 employees.

What is the current trading status of ST Pharm (237690)?

As of 27 Aug 2025, ST Pharm (237690) is trading at a price of 94,800.00, with a previous close of 94,300.00. The stock has fluctuated within a day range of 93,500.00 to 95,100.00, while its 52-week range spans from 66,600.00 to 120,800.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.